BioSight
Companies
Artiva Biotherapeutics, Inc. logo

ARTV

NASDAQSAN DIEGO, CA
Artiva Biotherapeutics, Inc.

Artiva Biotherapeutics is a clinical-stage biotech firm developing AlloNK, an allogeneic natural killer cell therapy for cancer treatment. The firm is preparing to submit investigational new drug applications to the FDA and is currently running clinical trials for AlloNK across multiple cancer indications. Artiva is also working on regulatory approval for its manufacturing facility in San Diego, California.

Price history not yet available for ARTV.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar